During cytokine storms in patients with COVID-19, interleukin (IL)-6 and tumor necrosis factor (TNF)-α have been used to reduce suppressive functions of T regulator cells, resulting in an increase in IL-17 and reduction in interferon (IFN)-γ expression in inflamed tissue [25,26]. Here, IL17A is linked to COVID-19.